Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 113320851000001118 | Ranitidine bismuth citrate (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 113320861000001115 | Ranitidine bismuth citrate | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ranitidine bismuth citrate | Is a | Product containing histamine H2 receptor antagonist | true | Inferred relationship | Existential restriction modifier | ||
| Ranitidine bismuth citrate | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ranitidine bismuth citrate 400 milligram/1 each conventional release oral tablet | Is a | True | Ranitidine bismuth citrate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR